期刊文献+

1株泛耐药肺炎克雷伯菌耐药机制的研究 被引量:4

The drug-resistant mechanism of a pan-resistant Klebsiella pneumoniae stain
下载PDF
导出
摘要 目的研究1株泛耐药肺炎克雷伯菌(Kpn)的耐药机制。方法用Vitek-2系统进行细菌鉴定,纸片扩散法和肉汤稀释法进行药敏试验;PCR和DNA测序检测β-内酰胺酶基因和7个管家基因,多位点序列分型(MLST)进行7个管家基因的序列分析;改良Hodge试验、超广谱β-内酰胺酶(ESBLs)确证试验、利用抑制剂的双纸片增效试验和改良ESBLs确证试验检测β-内酰胺酶表型。结果该菌株呈泛耐药性,携带KPC-2和CTX-M-15基因,MLST显示ST11型;改良Hodge试验检出碳青霉烯酶;ESBLs确证试验呈假阴性结果,改良ESBLs确证试验呈阳性结果;用3-氨基-苯酚硼酸(APBA)的双纸片增效试验呈阳性结果,显示产KPC型A类碳青霉烯酶。结论该菌株的泛耐药性可能是由于产KPC酶,利用抑制剂的表型试验能简便准确地检出KPC和ESBL。 Objective To study the drug-resistant mechanism of a pan-resistant Klebsiella pneumoniae (Kpn) strain. Methods The isolated strain was identified by using Vitek-2 compact automatic system, and antibiotic susceptibility was tested by Kirby-Bauer disc diffusion method and microbroth dilution method. The ^-lactamase genotypes and 7 housekeeping genes were detected by PCR and DNA sequencing. The nucleotide sequences of 7 housekeeping genes were determined by multilocus sequence typing (MLST). The phenotypes of extended-spectrum β-1actamase (ESBL) were identified by modified Hodge test (MHT), ESBL confirmatory tests, in- hibitor-potentiated double-disc diffusion test and modified ESBL confirmatory test. Results The strain was pan-resistant Kpn which carried bla_KPC-2 and bla_CTx-M-15. The sequence type was ST11. The result of modified Hedge test was positive. ESBL confirmatory test showed false negative results, but the modified ESBL confirmatory test was positive. The positive result of potentiated double-disc test using 3-aminophenylboronie acid (APBA) indicated Klebsiella pneumoniae carbapenemase (KPC) -producing strain. Conclusion The pan-resistance of the Kpn strain in this study may be aroused by production of KPC. The inhibitor-potentiated double-disc diffusion test for identification of phenotype should be available to detect KPC and ESBL easily and correctly.
出处 《临床检验杂志》 CAS CSCD 北大核心 2012年第6期426-429,共4页 Chinese Journal of Clinical Laboratory Science
基金 上海市浦东新区卫生局卫生科技发展专项基金(PW2011A-22)
关键词 泛耐药 肺炎克雷伯菌 多位点序列分型 KPC酶 双纸片增效试验 pan-resistance Klebsiella pneumoniae muhilocus sequence typing Klebsiella pneumoniae carbapenemase double-disc po-tentiation test
  • 相关文献

参考文献17

  • 1汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 2Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneu- moniae carbapenemase-producing bacteria [ J ]. Lancet Infect Dis, 2009, 9(4) :228-236.
  • 3Petrella S, Ziental-Gelus N, Mayer C, et al. Genetic and structural insights into the dissemination potential of the extremely broad-spec- trum class A β-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same pa- tient in France[ J]. Antimicrob Agents Chemother, 2008, 52(10) : 3725-3736.
  • 4王艳艳,刘红,杜昕,李刚,魏取好,陈晓耘,蒋晓飞.泛耐药肺炎克雷伯菌株的医院内流行特性的研究[J].中华微生物学和免疫学杂志,2011,31(3):208-212. 被引量:14
  • 5姚慧琳,范德胜,陆士海,刘培明.产KPC-2型碳青霉烯酶肠杆菌整合子分布研究[J].临床检验杂志,2012,30(4):281-283. 被引量:4
  • 6Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. Document M100-S22 [ S ]. Wayne, PA : Clinical and Laboratory Standards Institute, 2012.
  • 7王靖,李杰,李春英,张悦娴,贾红兵,鄢盛恺,衣美英.碳青霉烯类耐药肺炎克雷伯菌β-内酰胺酶检测和基因分型[J].临床检验杂志,2012,30(3):201-203. 被引量:11
  • 8Chen S, Hu F, Xu X, et al. High prevalence of KPC-2-type earbap- enemase coupled with CTX-M-type extended-spectrum 13-1actamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China [ J ]. Amimicrob Agents Chemother, 2011, 55 ( 5 ) : 2493- 2494.
  • 9Ikonomidis A, Tokatlidou D, Kristo I, et al. Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a blavlM_1 metallo-13-1actamase gene [ J ]. J Clin Microbiol, 2005, 43 ( 10 ) : 5344-5347.
  • 10Poirel L, H6ritier C, TolUn V, et al. Emergence of oxacillinase-me- diated resistance to imipenem in Klebsiella pneumoniae [ J ]. Antimi- crob Agents Chemother, 2004, 48( 1 ) : 15-22.

二级参考文献39

  • 1凌华志,李涛,徐元宏,曹红霞.假单胞菌属细菌中整合子的分布及其可转移耐药性研究[J].临床检验杂志,2007,25(1):10-12. 被引量:14
  • 2Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 3Clinical Laboratory crobial Dilution and Standard Institute Disk Susceptibility Methods for Antimi Testing of Infrequent ly Isolated or Fastidious Bacteria [S]. Approved Guideline M45-A, 2006, 26(19).
  • 4Yang QW, Wang H, Sun HL, et al. Phenotypic and geno typic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China[J]. Antimicrob Agents Chemother,2010, 54(1): 573-577.
  • 5Wang H, Guo P, Sun HL et al. Molecular epidemiology of clinical isolates of carbapenem resistant Acinetobacter spp from chinese hospitals[J]. Antimicrob Agents Chemother, 2007, 51(11): 4022-4028.
  • 6Perez F, Hujer AM, Hujer KM et al. Global challenge of multidrug resistantAcinetobacterbaumannii[J]. Antimicrob Agents Chemother,2007,51(10) : 3471-3484.
  • 7Boucher HW, Talbot G, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the IDSA[J]. Clin Infent Dis, 2009, 48(1):1-12.
  • 8Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria [J]. Intl J Antimicrob Agents, 2005, 25(1).-11 25.
  • 9Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae : a report of 2 cases and a brief review of the literature[J]. Clin Infent Dis, 2009,49(2):271-274.
  • 10Pachon Ibanez ME, Jimenez Mejias ME, Pichardo C, et al Activity of tigeeyeline (GAR 936) against Acinetobacter bau mannii strains, including those resistant to imipenem[J] Antimicrob Agents Chemother, 2004,48 ( 11 ):4479-4481.

共引文献419

同被引文献59

  • 1Klugman KP. The successful clone : the vector of dissemination of re- sistance in Streptococcus pneumoniae [ J ]. J Antimicrob Chemother, 2002,50 ( Suppl S2 ) : 1-5.
  • 2Leplae R, Lima-Mendez G, Toussaint A. A first global analysis of plasmid encoded proteins in the ACLAME database [ J ]. FEMS Mi- crobiol Rev, 2006,30(6) : 980-994.
  • 3Livermore DM, Canton R, Gniadkowski M, et al. CTX-M : changing the face of ESBLs in Europe[J]. J Antimicrob Chemother, 2007,59 (2) :165-174.
  • 4Canton R, Coque TM. The CTX-M 13-1actamase pandemic[J]. Curr Opin Microbio1,2006,9(5 ) : 466-475.
  • 5Guembe M, Cercenado E, Alcal6 L, et al. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007 [ J]. Rev Esp Quimioter, 2008,21 (3) : 166-173.
  • 6Hawkey PM. Prevalence and clonality of extended-spectrum 13-1acta- mases in Asia [ J ]. Clin Microbiol Infect, 2008, 14 ( Suppl 1 ) :.
  • 7Liu W, Chen L, Li H, et al. Novel CTX-M -lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China[J]. J Antimicrob Chemother, 2009, 63 (5) :895-900.
  • 8Jacoby GA. AmpC-lactamases [ J ]. Clin Microbiol Rev, 2009,22 (1) :161-182.
  • 9Ding H, Yang Y, Lu Q, et al. The prevalence of plasmid-mediated AmpC -lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China[ J]. Eur J Clin Microbiol Infect Dis, 2005,27(10) : 915-921.
  • 10Queenan AM, Bush K. Carbapenemases : the Versatile 13-Lactamas- es[J]. Clin Microbiol Rev, 2007,20(3) :440-458.

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部